Main

id

4213303

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-05 18:06:45

expired found date

-

created at

2024-05-28 23:23:41

updated at

2025-12-24 08:26:06

Domain name statistics

length

9

crc

9558

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

0

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

33599

mp size raw text

3861

mp inner links count

10

mp inner links status

20 (imported)

Open Graph

title

XORTX Therapeutics Inc.

description

site name

XORTX Therapeutics Inc.

author

updated

2025-12-07 07:10:19

raw text

XORTX Therapeutics Inc. (XRTX) Skip to main content Skip to footer Home About Overview Management Team Board of Directors Advisory Board Pipeline Overview XRx-008 for Autosomal Dominant Polycystic Kidney Disease XRx-101 for Coronavirus/COVID-19 XRX-225 for Type 2 Diabetic Nephropathy Publications Technology News & Media Press Releases Events In the News Investors Overview News & Events Presentations Company Info Financial Info Stock Data SEC Filings SEDAR+ Governance Contact Pioneering New Therapies for Progressive Kidney Disease We are XORTX Therapeutics, a late stage clinical pharmaceutical company dedicated to developing innovative therapies to improve the quality of life of patients with progressive kidney disease. Our programs are designed to manage aberrant purine metabolism and reduce high uric acid and slow progression of kidney disease. About our company Developing First-in-class Uric Acid Lowering Agents We...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Koronawirus (17)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2826

text words

504

text unique words

262

text lines

87

text sentences

18

text paragraphs

6

text words per sentence

28

text matched phrases

5

text matched dictionaries

4

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

43

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-08 14:07:06

sitemap process date

2024-08-05 10:01:34

sitemap first import date

-

sitemap last import date

-